Telix and Regeneron Pharmaceuticals, Inc. announce a collaboration to jointly develop and commercialize next generation radiopharmaceutical therapies. The collaboration combines Telix’s radiopharmaceutical development platform, global manufacturing capabilities and supply chain infrastructure with Regene…
Haisco Pharmaceutical Group Co., Ltd. announced that it has entered into an exclusive licensing agreement with AbbVie, a global biopharmaceutical company. Under the agreement, Haisco grants AbbVie the exclusive rights to develop, manufacture, and commercialize novel medicines for the treatment of pain globally, exclud…
GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the pioneer in Molecular Archive Technology™, announced a strategic collaboration to industrialize DNA-based data storage, a technology poised to transform how the world preserves data in the age of …
GTCR, a leading private equity firm, announced that it has closed the previously announced acquisition of Zentiva, a leading European generics pharmaceutical company, from Advent, a leading global private equity investor. GTCR will partner with Zentiva's management team, led by Chief Executive Officer Steffen Saltoft…
ABK Biomedical, Inc. and COR Development are proud to announce a strategic partnership to develop a state-of-the-art GMP manufacturing facility in Cartwright Business Park, Ashland, Missouri. This strategic project will provide the long-term future commercial scale production of Eye90 microspheres®, a designated FDA b…
Cytiva, a Danaher company and a leader in the life sciences industry, announced that it has signed a FlexFactory™ contract with Yoshindo, supporting the company’s plans to establish domestic biosimilar drug substances manufacturing capabilities for the Japanese market. Yoshindo plans to begin supplying biosimilar pro…
ICON plc, a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connected, intelligence-powered research technology, have entered a definitive partnership agreement to introduce a new ‘research-ready,’ connected site network model for clinical tr…
Eli Lilly and Company and Centessa Pharmaceuticals plc, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, today announced a definitive agreement for Lilly to acquire Centessa. "Centessa is at the forefront of orexin scienc…
Adragos Pharma, a global contract development and manufacturing organization (CDMO), announced that it completed the acquisition of a commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi. The Maisons-Alfort site is one of Europe’s largest manufacturing facilities for sterile injectables…
Global pharma major Lupin Limited announced the completion of its acquisition of VISUfarma B.V. (VISUfarma), a leading European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP (GHO). The acquisition represents a significant milestone in Lupin's strategy to expand its specialty …
Page 15 of 40